Mobocertinib (TAK-788) is an investigational TKI with potent, selective preclinical activity against activating EGFR and HER2 mutations, including exon 20 insertions.
Molecular Weight:
585.7
Purity:
99.34%
CAS Number:
[1847461-43-1]
Formula:
C32H39N7O4
Target:
EGFR/HER2
* VAT and and shipping costs not included. Errors and price changes excepted
